Maha Nasr
AGYA Alumni Jointly building bridges into the future
About me
My main research focus is on the formulation of nanoparticles from different safe and biodegradable materials, and on testing their applications pre-clinically and clinically. I am particularly focused on loading nutraceuticals in nanoparticles to minimize the side effects of conventional treatments and to maximize the therapeutic outcome for different diseases, such as cancer, Alzheimer’s and dermatological diseases.
I am really proud to be a member of such a vibrant academy, since it provides numerous opportunities and extensive collaboration networks for its members.
From mobility grants to tandem research projects and collaborative working group meetings and projects, AGYA boosts its members’ professional careers. By providing me with support to do cutting edge research in collaboration with German and Arab scientists, and allowing me to engage in societal projects and initiatives in an interdisciplinary manner, AGYA has taken my career to the next level.
- AGYA Publications
- Ferulic acid nanoemulsion as a promising anti-ulcer tool: in vitro and in vivo assessment
- Deferasirox a comprehensive drug profile
- Recent progress on polySarcosine as an alternative to PEGylation: Synthesis and biomedical applications
- Gastroprotective Chitosan Nanoparticles Loaded with Oleuropein: An In Vivo Proof of Concept
- Pterostilbene lipid nanocapsules as a promising system for treatment of hepatocellular carcinoma: Formulation, characterization, and cellular/in vivo appraisal
- Silymarin chitosan-modified penetration enhancer microvesicles as a promising wound healing tool
- Folic/lactobionic acid dual-targeted polymeric nanocapsules for potential treatment of hepatocellular carcinoma
- Ferulic acid nanocapsules as a promising treatment modality for colorectal cancer: Preparation and in vitro/in vivo appraisal
- Oleuropein as a Novel Topical Antipsoriatic Nutraceutical: Formulation in Microemulsion Nanocarrier and Exploratory Clinical Appraisal
- Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma
- My commitment to AGYA
- Acting Alumni Co-Speaker
- AGYA Co-President 2020/2021
- Member of the AGYA Steering Committee 2019-2021
- Selection Committee 'New AGYA Members' 2020
On a personal note
Must read in my discipline:
Martin’s Physical Pharmacy and Pharmaceutical Sciences by Patrick J. Sinko
Favourite novel:
The Cairo Trilogy by Naguib Mahfouz
The scientist from my country you should know:
Ahmed Zewail, known as the “Father of Femtochemistry”